Cargando…
Osteochondral scaffolds for early treatment of cartilage defects in osteoarthritic joints: from bench to clinic
Osteoarthritis is a degenerative joint disease, typified by the loss in the quality of cartilage and bone at the interface of a synovial joint, resulting in pain, stiffness and reduced mobility. The current surgical treatment for advanced stages of the disease is joint replacement, where the non-sur...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Chinese Medical Multimedia Press Co., Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9255817/ https://www.ncbi.nlm.nih.gov/pubmed/35837659 http://dx.doi.org/10.3877/cma.j.issn.2096-112X.2020.01.002 |
_version_ | 1784740999671578624 |
---|---|
author | Tamaddon, Maryam Gilja, Helena Wang, Ling Oliveira, J. Miguel Sun, Xiaodan Tan, Rongwei Liu, Chaozong |
author_facet | Tamaddon, Maryam Gilja, Helena Wang, Ling Oliveira, J. Miguel Sun, Xiaodan Tan, Rongwei Liu, Chaozong |
author_sort | Tamaddon, Maryam |
collection | PubMed |
description | Osteoarthritis is a degenerative joint disease, typified by the loss in the quality of cartilage and bone at the interface of a synovial joint, resulting in pain, stiffness and reduced mobility. The current surgical treatment for advanced stages of the disease is joint replacement, where the non-surgical therapeutic options or less invasive surgical treatments are no longer effective. These are major surgical procedures which have a substantial impact on patients’ quality of life and lifetime risk of requiring revision surgery. Treatments using regenerative methods such as tissue engineering methods have been established and are promising for the early treatment of cartilage degeneration in osteoarthritis joints. In this approach, 3-dimensional scaffolds (with or without cells) are employed to provide support for tissue growth. However, none of the currently available tissue engineering and regenerative medicine products promotes satisfactory durable regeneration of large cartilage defects. Herein, we discuss the current regenerative treatment options for cartilage and osteochondral (cartilage and underlying subchondral bone) defects in the articulating joints. We further identify the main hurdles in osteochondral scaffold development for achieving satisfactory and durable regeneration of osteochondral tissues. The evolution of the osteochondral scaffolds – from monophasic to multiphasic constructs – is overviewed and the osteochondral scaffolds that have progressed to clinical trials are examined with respect to their clinical performances and their potential impact on the clinical practices. Development of an osteochondral scaffold which bridges the gap between small defect treatment and joint replacement is still a grand challenge. Such scaffold could be used for early treatment of cartilage and osteochondral defects at early stage of osteoarthritis and could either negate or delay the need for joint replacements. |
format | Online Article Text |
id | pubmed-9255817 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Chinese Medical Multimedia Press Co., Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-92558172022-07-13 Osteochondral scaffolds for early treatment of cartilage defects in osteoarthritic joints: from bench to clinic Tamaddon, Maryam Gilja, Helena Wang, Ling Oliveira, J. Miguel Sun, Xiaodan Tan, Rongwei Liu, Chaozong Biomater Transl Review Osteoarthritis is a degenerative joint disease, typified by the loss in the quality of cartilage and bone at the interface of a synovial joint, resulting in pain, stiffness and reduced mobility. The current surgical treatment for advanced stages of the disease is joint replacement, where the non-surgical therapeutic options or less invasive surgical treatments are no longer effective. These are major surgical procedures which have a substantial impact on patients’ quality of life and lifetime risk of requiring revision surgery. Treatments using regenerative methods such as tissue engineering methods have been established and are promising for the early treatment of cartilage degeneration in osteoarthritis joints. In this approach, 3-dimensional scaffolds (with or without cells) are employed to provide support for tissue growth. However, none of the currently available tissue engineering and regenerative medicine products promotes satisfactory durable regeneration of large cartilage defects. Herein, we discuss the current regenerative treatment options for cartilage and osteochondral (cartilage and underlying subchondral bone) defects in the articulating joints. We further identify the main hurdles in osteochondral scaffold development for achieving satisfactory and durable regeneration of osteochondral tissues. The evolution of the osteochondral scaffolds – from monophasic to multiphasic constructs – is overviewed and the osteochondral scaffolds that have progressed to clinical trials are examined with respect to their clinical performances and their potential impact on the clinical practices. Development of an osteochondral scaffold which bridges the gap between small defect treatment and joint replacement is still a grand challenge. Such scaffold could be used for early treatment of cartilage and osteochondral defects at early stage of osteoarthritis and could either negate or delay the need for joint replacements. Chinese Medical Multimedia Press Co., Ltd 2020-12-28 /pmc/articles/PMC9255817/ /pubmed/35837659 http://dx.doi.org/10.3877/cma.j.issn.2096-112X.2020.01.002 Text en https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Review Tamaddon, Maryam Gilja, Helena Wang, Ling Oliveira, J. Miguel Sun, Xiaodan Tan, Rongwei Liu, Chaozong Osteochondral scaffolds for early treatment of cartilage defects in osteoarthritic joints: from bench to clinic |
title | Osteochondral scaffolds for early treatment of cartilage defects in osteoarthritic joints: from bench to clinic |
title_full | Osteochondral scaffolds for early treatment of cartilage defects in osteoarthritic joints: from bench to clinic |
title_fullStr | Osteochondral scaffolds for early treatment of cartilage defects in osteoarthritic joints: from bench to clinic |
title_full_unstemmed | Osteochondral scaffolds for early treatment of cartilage defects in osteoarthritic joints: from bench to clinic |
title_short | Osteochondral scaffolds for early treatment of cartilage defects in osteoarthritic joints: from bench to clinic |
title_sort | osteochondral scaffolds for early treatment of cartilage defects in osteoarthritic joints: from bench to clinic |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9255817/ https://www.ncbi.nlm.nih.gov/pubmed/35837659 http://dx.doi.org/10.3877/cma.j.issn.2096-112X.2020.01.002 |
work_keys_str_mv | AT tamaddonmaryam osteochondralscaffoldsforearlytreatmentofcartilagedefectsinosteoarthriticjointsfrombenchtoclinic AT giljahelena osteochondralscaffoldsforearlytreatmentofcartilagedefectsinosteoarthriticjointsfrombenchtoclinic AT wangling osteochondralscaffoldsforearlytreatmentofcartilagedefectsinosteoarthriticjointsfrombenchtoclinic AT oliveirajmiguel osteochondralscaffoldsforearlytreatmentofcartilagedefectsinosteoarthriticjointsfrombenchtoclinic AT sunxiaodan osteochondralscaffoldsforearlytreatmentofcartilagedefectsinosteoarthriticjointsfrombenchtoclinic AT tanrongwei osteochondralscaffoldsforearlytreatmentofcartilagedefectsinosteoarthriticjointsfrombenchtoclinic AT liuchaozong osteochondralscaffoldsforearlytreatmentofcartilagedefectsinosteoarthriticjointsfrombenchtoclinic |